Tuberculosis

MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options

Geneva — The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) today welcomed the new World Health Organization (WHO) recommendations for improved treatment for people with drug-resistant tuberculosis (DR-TB), prioritising the use of several oral drugs, including the newer drug bedaquiline, and minimising the use of drugs that must be injected.
 

Last-minute pressured to drop language on protecting access to affordable meds from TB Summit declaration negotiations

New York - Countries negotiating the final declaration text for the first-ever UN High-level Meeting on Tuberculosis in September are being put under significant pressure to drop all references to protecting countries’ rights to take fully-legal actions to access affordable medicines for their people, Doctors Without Borders/Médecins Sans Frontières (MSF) reported learning today.

MSF responds to India’s first-ever national anti-tuberculosis drug resistance survey

India’s Ministry of Health recently released the “Report of the First National Anti-Tuberculosis Drug Resistance Survey”. According to the report, the survey is the largest national drug-resistant (DR) TB survey ever conducted by any country in the world. The survey results reveal that more than 6% of all TB patients in India have multidrug-resistant TB (MDR-TB).

Submitted by admin on March 24, 2018

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

 

For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). 

Pooja, Rekha, Vikas and Sita are receiving care in MSF’s DR-TB programme in Mumbai, where a multi-disciplinary MSF team is providing patients with resistant strains of TB with individual regimens of drugs are tailored according to their individual needs. This includes a combination of the two newest DR-TB drugs, bedaquiline and delamanid as part of their treatment regimen.

Submitted by admin on November 20, 2017

#StepUpforTB: At first global ministerial meeting on TB, MSF and Stop TB Partnership give governments deadline to dramatically increase access to testing and treatment

Moscow/Geneva, 15 November 2017 — Ahead of the first-ever Global Ministerial Conference on ‘Ending TB’ in Moscow, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership called for countries with high burdens of tuberculosis (TB) to implement the latest international treatment and testing standards by World TB Day, 24 March 2018.

People still being denied improved treatment for multidrug-resistant TB

MSF urges governments to step up the use of newer TB drugs

Guadalajara, Mexico, October 13, 2017 - People with multidrug-resistant tuberculosis (MDR-TB) are still not receiving two newer TB drugs, bedaquiline and delamanid, which have been available for more than four years and have shown improved cure rates for the disease, deplored Doctors Without Borders/Médecins Sans Frontières (MSF) at the 48th Union World Conference on Lung Health in Guadalaja

Why India’s TB control is faltering: Poor diagnostics, drug supply disruptions and no counselling

India’s tuberculosis control programme is not fully equipped to prevent, diagnose, and treat patients. The Revised National Tuberculosis Control Program uses outdated diagnostic techniques, suffers from repeated medicine stock-outs and lacks capacity to counsel tuberculosis patients, according to the Out of Step report released by the Stop TB Partnership and Médecins Sans Frontières last week.

Tuberculosis: New report reveals that countries are still not tackling world’s deadliest infectious disease

Hamburg/Geneva, 5 July 2017 — Two days ahead of the G20 summit in Germany, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released the third edition of ‘Out of Step,’ a report highlighting the need for governments to increase efforts to combat tuberculosis (TB). The report reviews TB policies and practices in 29[1] countries – which account for 82% of the global TB burden – and shows that countries can do much more to prevent, diagnose and treat people affected by TB.